Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 321 results for "cipla"

Cipla stocks rise 4% after tie up with Serum Institute
Money Today

Cipla, SII tie up for marketing pediatric vaccines

Marking a foray into the vaccines segment, pharmaceuticals company Cipla has joined hands with vaccine maker Serum Institute of India (SII) for developing and manufacturing pediatric vaccines, to be marketed in the European region. The ... Financial Chronicle, 2 hours ago
Cipla spurts 4% on pact with Serum Inst Hindu Business Line, 8 hours ago

58 images for cipla

Money Today, 8 hours ago
NDTV Profit, 14 hours ago, 14 hours ago
Jagran Post, 14 hours ago
One News Page United Kingdom, 12 hours ago
Money Control, 13 hours ago
India TV, 6 days ago
Money Today, 6 days ago
Business Today India, 6 days ago
Jagran Post, 14 hours ago
Business Standard

Cipla gains on distribution pact to market paediatric vaccines in Europe

The stock moved higher by 3% to Rs 618 on BSE. SI Reporter | Mumbai November 20, 2014 Last Updated at 14:19 IST Cipla has moved higher by 3% to Rs 618 in otherwise weak market on BSE after the pharmaceutical company through its subsidiary Cipla Europe NV, has ...
 Business Standard12 hours ago Cipla forms alliance with Serum Institute to market paediatric vaccines in Europe  Business Standard13 hours ago Cipla gains on expansion plan in Europe  Business Standard14 hours ago Cipla to market Serum Institute's paediatric vaccines in Europe  Reuters India15 hours ago
Business Standard

Cipla enters strategic Europe-specific marketing pact with Serum Institute

Cipla Europe NV (Cipla), a 100% subsidiary of Cipla Ltd and a global pharmaceutical company has entered a distribution agreement with Serum Institute of India Ltd. (SII) a global leader in the production of vaccines. Under the agreement, SII will ...
 PharmaBiz15 hours ago Cipla announces distribution agreement with Serum Institute...stock flat  India Infoline15 hours ago Cipla surges as its arm inks distribution pact with Serum Institute of India  Arihant Capital15 hours ago Cipla gains on signing distribution agreement with Serum Institute  Business Standard6 hours ago

Cipla-Serum ally to take vaccines into Europe

Drugmaker Cipla and vaccines maker Serum Institute of India have entered into a distribution agreement to sell affordable paediatric vaccines in Europe. Serum will develop and manufacture the paediatric vaccines and Cipla will seek regulatory ...
 Hindu Business Line15 hours ago Cipla links with SII for affordable pediatric vaccines in Europe  Pharma Letter8 hours ago

Hamid grooming niece, nephew for a role in Cipla corner room

MUMBAI: Cipla Chairman Yusuf K Hamied is grooming niece and nephew Samina Vaziralli and Kamil Hamied as the next generation of leaders at India's third-biggest pharmaceutical company, but he's by no means done setting tough challenges for himself.
 Economic Times1 day ago Cipla's Hamied grooms niece & nephew as genext leaders  Economic Times2 days ago

Lupin, Sun Pharma good bets in the pharma space: Ambareesh Baliga

Cipla will still see slightly lower levels because it was a late mover and the financial results did not really keep up. DON'T MISS any stories, follow us on Twitter Follow Follow this section for latest news on Recos EmailRSS Have something to say? Post your ...
 Economic Times1 day ago

We will deliver biotech at a Dollar a day. Wait and see: Yusuf Khwaja Hamied, Chairman of Cipla

, 78, came to the world's attention in 2001 when he said his company Cipla would make AIDS medicines for $1 a day, at a time when the disease was ravaging the poor in Africa and elsewhere and such drugs were prohibitively expensive for most. More importantly, ...
 Economic Times1 day ago Will deliver biotech at a Dollar a day: Yusuf Hamied, Cipla Chief  Economic Times1 day ago
Money Today

Cipla 2QFY2015 performance highlights and results update

Y2015 results have come in below expectations on all fronts. For the period, the company posted sales of Rs.2,630cr (V/s an expected Rs.2,889cr), a growth of 5.9% yoy. On the operating front, the gross margin came in at 61.4% (V/s an expected ...
 Stock Markets Review3 days ago Cipla shares down 2.4 % post Q2 results  Business Standard6 days ago Cipla falls 3% post below expected Q2 numbers  Money Control6 days ago Cipla consolidated net falls by 16.5% in Q2  PharmaBiz6 days ago
Money Today

Cipla announces board changes

Cipla Limited, a pharmaceutical and biotechnology company, has announced the appointment of Punita Lal and Nachiket Mor as the independent directors of its board. Post a successful executive career, Ms Lal is now focused on advisory roles. She sits ...
 Individual.com2 days ago CIPLA : appoints Ms.Punita Lal and Dr. Nachiket Mor as Independent Directors on its Board  4 Traders3 days ago Punita Lal, Nachiket Mor join Cipla board  Business Today India6 days ago

Cipla consolidated net profit declines 16.58% in the September 2014 quarter

Sales rise 5.89% to Rs 2629.81 crore
 Business Standard6 days ago Cipla standalone net profit declines 10.63% in the September 2014 quarter  Business Standard6 days ago TVS Motor Net Rises; Cipla, HCL, SAIL Net Fall  Ticker6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less